Impact of repetitive transcranial magnetic stimulation on post-stroke dysmnesia and the role of BDNF Val66Met SNP

Haitao Lu, Tong Zhang, Mei Wen, Li Sun, Haitao Lu, Tong Zhang, Mei Wen, Li Sun

Abstract

Background: Little is known about the effects of low-frequency repetitive transcranial magnetic stimulation (rTMS) on dysmnesia and the impact of brain nucleotide neurotrophic factor (BDNF) Val66Met single-nucleotide polymorphism (SNP). This study investigated the impact of low-frequency rTMS on post-stroke dysmnesia and the impact of BDNF Val66Met SNP.

Material and methods: Forty patients with post-stroke dysmnesia were prospectively randomized into the rTMS and sham groups. BDNF Val66Met SNP was determined using restriction fragment length polymorphism. Montreal Cognitive Assessment (MoCA), Loewenstein Occupational Therapy of Cognitive Assessment (LOTCA), and Rivermead Behavior Memory Test (RBMT) scores, as well as plasma BDNF concentrations, were measured at baseline and at 3 days and 2 months post-treatment.

Results: MoCA, LOTCA, and RBMT scores were higher after rTMS. Three days after treatment, BDNF decreased in the rTMS group but it increased in the sham group (P<0.05). Two months after treatment, RMBT scores in the rTMS group were higher than in the sham group, but not MoCA and LOTCA scores.

Conclusions: Low-frequency rTMS may improve after-stoke memory through various pathways, which may involve polymorphisms and several neural genes, but not through an increase in BDNF levels.

References

    1. Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics – 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119:e21–181.
    1. Young JA, Tolentino M. Stroke evaluation and treatment. Top Stroke Rehabil. 2009;16:389–410.
    1. Annoni JM, Staub F, Bruggimann L, et al. Emotional disturbances after stroke. Clin Exp Hypertens. 2006;28:243–49.
    1. Erkinjuntti T. Diagnosis and management of vascular cognitive impairment and dementia. J Neural Transm Suppl. 2002;(63):91–109.
    1. Loewenstein DA, Acevedo A, Agron J, et al. Cognitive profiles in Alzheimer’s disease and in mild cognitive impairment of different etiologies. Dement Geriatr Cogn Disord. 2006;21:309–15.
    1. Stephens S, Kenny RA, Rowan E, et al. Neuropsychological characteristics of mild vascular cognitive impairment and dementia after stroke. Int J Geriatr Psychiatry. 2004;19:1053–57.
    1. Ingles JL, Boulton DC, Fisk JD, Rockwood K. Preclinical vascular cognitive impairment and Alzheimer disease: neuropsychological test performance 5 years before diagnosis. Stroke. 2007;38:1148–53.
    1. Reed BR, Eberling JL, Mungas D, et al. Effects of white matter lesions and lacunes on cortical function. Arch Neurol. 2004;61:1545–50.
    1. Cramer SC. Repairing the human brain after stroke. II. Restorative therapies. Ann Neurol. 2008;63:549–60.
    1. Jordan LA, Mackey E, Coughlan K, et al. Continence management in acute stroke: a survey of current practices in Australia. J Adv Nurs. 2011;67:94–104.
    1. Patel M, Coshall C, Rudd AG, Wolfe CD. Natural history and effects on 2-year outcomes of urinary incontinence after stroke. Stroke. 2001;32:122–27.
    1. Harnish SM, Neils-Strunjas J, Lamy M, Eliassen JC. Use of fMRI in the study of chronic aphasia recovery after therapy: a case study. Top Stroke Rehabil. 2008;15:468–83.
    1. Pulvermuller F, Berthier ML. Aphasia therapy on a neuroscience basis. Aphasiology. 2008;22:563–99.
    1. Meinzer M, Djundja D, Barthel G, et al. Long-term stability of improved language functions in chronic aphasia after constraint-induced aphasia therapy. Stroke. 2005;36:1462–66.
    1. Barrett AM, Crucian GP, Schwartz RL, Heilman KM. Adverse effect of dopamine agonist therapy in a patient with motor-intentional neglect. Arch Phys Med Rehabil. 1999;80:600–3.
    1. Hillis AE. Rehabilitation of unilateral spatial neglect: new insights from magnetic resonance perfusion imaging. Arch Phys Med Rehabil. 2006;87:S43–49.
    1. Piras F, Borella E, Incoccia C, Carlesimo GA. Evidence-based practice recommendations for memory rehabilitation. Eur J Phys Rehabil Med. 2011;47:149–75.
    1. Miniussi C, Rossini PM. Transcranial magnetic stimulation in cognitive rehabilitation. Neuropsychol Rehabil. 2011;21:579–601.
    1. Ma J, Zhang Z, Su Y, et al. Magnetic stimulation modulates structural synaptic plasticity and regulates BDNF-TrkB signal pathway in cultured hippocampal neurons. Neurochem Int. 2013;62:84–91.
    1. Cohen-Cory S, Kidane AH, Shirkey NJ, Marshak S. Brain-derived neurotrophic factor and the development of structural neuronal connectivity. Dev Neurobiol. 2010;70:271–88.
    1. Pezawas L, Verchinski BA, Mattay VS, et al. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci. 2004;24:10099–102.
    1. Kambeitz JP, Bhattacharyya S, Kambeitz-Ilankovic LM, et al. Effect of BDNF val(66)met polymorphism on declarative memory and its neural substrate: a meta-analysis. Neurosci Biobehav Rev. 2012;36:2165–77.
    1. Munno D, Sterpone S, Fania S, et al. Plasma brain derived neurotrophic factor levels and neuropsychological aspects of depressed patients treated with paroxetine. Panminerva Med. 2013;55:377–84.
    1. Gangitano M, Valero-Cabre A, Tormos JM, et al. Modulation of input-output curves by low and high frequency repetitive transcranial magnetic stimulation of the motor cortex. Clin Neurophysiol. 2002;113:1249–57.
    1. Speer AM, Kimbrell TA, Wassermann EM, et al. Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients. Biol Psychiatry. 2000;48:1133–41.
    1. Boggio PS, Rocha M, Oliveira MO, et al. Noninvasive brain stimulation with high-frequency and low-intensity repetitive transcranial magnetic stimulation treatment for posttraumatic stress disorder. J Clin Psychiatry. 2010;71:992–99.
    1. Ahmed MA, Darwish ES, Khedr EM, et al. Effects of low versus high frequencies of repetitive transcranial magnetic stimulation on cognitive function and cortical excitability in Alzheimer’s dementia. J Neurol. 2012;259:83–92.
    1. Tan T, Xie J, Liu T, et al. Low-frequency (1 Hz) repetitive transcranial magnetic stimulation (rTMS) reverses Abeta(1-42)-mediated memory deficits in rats. Exp Gerontol. 2013;48:786–94.
    1. Rossi S, Hallett M, Rossini PM, Pascual-Leone A. Safety of TMSCG Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009;120:2008–39.
    1. Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–99.
    1. Zwecker M, Levenkrohn S, Fleisig Y, et al. Mini-Mental State Examination, cognitive FIM instrument, and the Loewenstein Occupational Therapy Cognitive Assessment: relation to functional outcome of stroke patients. Arch Phys Med Rehabil. 2002;83:342–45.
    1. Wilson BA. The Rivermead behavioural memory test. Thames Valley Test Company; 1991.
    1. Ruffini C, Locatelli M, Lucca A, Benedetti F, Insacco C, et al. Augmentation effect of repetitive transcranial magnetic stimulation over the orbitofrontal cortex in drug-resistant obsessive-compulsive disorder patients: a controlled investigation. Prim Care Companion J Clin Psychiatry. 2009;11:226–30.
    1. Adams RJ, Albers G, Alberts MJ, et al. Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke. 2008;39:1647–52.
    1. Gazzaniga MS, Ivry RB, Mangun GR. Neurosciences cognitives: La biologie de l’esprit. De Boeck Supérieur. 2000
    1. Balconi M. Dorsolateral prefrontal cortex, working memory and episodic memory processes: insight through transcranial magnetic stimulation techniques. Neurosci Bull. 2013;29:381–89.
    1. Blumenfeld RS, Lee TG, D’Esposito M. The effects of lateral prefrontal transcranial magnetic stimulation on item memory encoding. Neuropsychologia. 2014;53:197–202.
    1. Rossi S, Cappa SF, Babiloni C, et al. Prefrontal [correction of Prefontal] cortex in long-term memory: an “interference” approach using magnetic stimulation. Nat Neurosci. 2001;4:948–52.
    1. Sandrini M, Cappa SF, Rossi S, et al. The role of prefrontal cortex in verbal episodic memory: rTMS evidence. J Cogn Neurosci. 2003;15:855–61.
    1. Turriziani P, Smirni D, Zappala G, et al. Enhancing memory performance with rTMS in healthy subjects and individuals with Mild Cognitive Impairment: the role of the right dorsolateral prefrontal cortex. Front Hum Neurosci. 2012;6:62.
    1. Vilberg KL, Rugg MD. Memory retrieval and the parietal cortex: a review of evidence from a dual-process perspective. Neuropsychologia. 2008;46:1787–99.
    1. Valero-Cabre A, Pascual-Leone A, Rushmore RJ. Cumulative sessions of repetitive transcranial magnetic stimulation (rTMS) build up facilitation to subsequent TMS-mediated behavioural disruptions. Eur J Neurosci. 2008;27:765–74.
    1. Selimbeyoglu A, Parvizi J. Electrical stimulation of the human brain: perceptual and behavioral phenomena reported in the old and new literature. Front Hum Neurosci. 2010;4:46.
    1. Zanardini R, Gazzoli A, Ventriglia M, et al. Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients. J Affect Disord. 2006;91:83–86.
    1. Yukimasa T, Yoshimura R, Tamagawa A, et al. High-frequency repetitive transcranial magnetic stimulation improves refractory depression by influencing catecholamine and brain-derived neurotrophic factors. Pharmacopsychiatry. 2006;39:52–59.
    1. Yoshimura R, Ikenouchi-Sugita A, Hori H, et al. [Blood levels of brain-derived neurotrophic factor (BDNF) in major depressive disorder]. Seishin Shinkeigaku Zasshi. 2010;112:982–85. [in Japanese]
    1. Lang UE, Bajbouj M, Gallinat J, Hellweg R. Brain-derived neurotrophic factor serum concentrations in depressive patients during vagus nerve stimulation and repetitive transcranial magnetic stimulation. Psychopharmacology (Berl) 2006;187:56–59.
    1. Schaller G, Sperling W, Richter-Schmidinger T, et al. Serial repetitive transcranial magnetic stimulation (rTMS) decreases BDNF serum levels in healthy male volunteers. J Neural Transm. 2014;121:307–13.
    1. Angelucci F, Oliviero A, Pilato F, et al. Transcranial magnetic stimulation and BDNF plasma levels in amyotrophic lateral sclerosis. Neuroreport. 2004;15:717–20.
    1. Mirowska-Guzel D, Gromadzka G, Seniow J, et al. Association between BDNF-196 G>A and BDNF-270 C>T polymorphisms, BDNF concentration, and rTMS-supported long-term rehabilitation outcome after ischemic stroke. NeuroRehabilitation. 2013;32:573–82.
    1. Nagappan G, Zaitsev E, Senatorov VV, Jr, et al. Control of extracellular cleavage of ProBDNF by high frequency neuronal activity. Proc Natl Acad Sci USA. 2009;106:1267–72.
    1. Wang F, Geng X, Tao HY, Cheng Y. The restoration after repetitive transcranial magnetic stimulation treatment on cognitive ability of vascular dementia rats and its impacts on synaptic plasticity in hippocampal CA1 area. J Mol Neurosci. 2010;41:145–55.
    1. Yue L, Xiao-lin H, Tao S. The effects of chronic repetitive transcranial magnetic stimulation on glutamate and gamma-aminobutyric acid in rat brain. Brain Res. 2009;1260:94–99.
    1. McAllister TW, Tyler AL, Flashman LA, et al. Polymorphisms in the brain-derived neurotrophic factor gene influence memory and processing speed one month after brain injury. J Neurotrauma. 2012;29:1111–18.
    1. Witte AV, Kurten J, Jansen S, et al. Interaction of BDNF and COMT polymorphisms on paired-associative stimulation-induced cortical plasticity. J Neurosci. 2012;32:4553–61.
    1. Yeh TK, Hu CY, Yeh TC, et al. Association of polymorphisms in BDNF, MTHFR, and genes involved in the dopaminergic pathway with memory in a healthy Chinese population. Brain Cogn. 2012;80:282–89.
    1. Gong P, Zheng Z, Chi W, et al. An association study of the genetic polymorphisms in 13 neural plasticity-related genes with semantic and episodic memories. J Mol Neurosci. 2012;46:352–61.
    1. Yogeetha BS, Haupt LM, McKenzie K, et al. BDNF and TNF-alpha polymorphisms in memory. Mol Biol Rep. 2013;40:5483–90.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj